Related Experiment Video

Updated: Jun 13, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

Extracellular vesicles-hitchhiking boosts the deep penetration of drugs to amplify anti-tumor efficacy

Min Gao1, Qiuting Sun2, Ruijie Zhang2

  • 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, PR China.

Biomaterials
|September 14, 2024
PubMed

Insights

This study introduces a novel cell membrane vector for attaching antitumor drugs to extracellular vesicles (EVs). This strategy enhances drug delivery deep into tumors, improving phototherapy efficacy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Achieving deep tumor penetration for drug delivery systems remains a significant challenge in cancer treatment.
  • Extracellular vesicles (EVs) offer a promising platform for drug delivery, but limited drug loading onto EVs hinders their application.
  • Effective drug delivery systems are crucial for enhancing the efficacy of cancer therapies.

Purpose of the Study:

  • To develop an efficient method for attaching antitumor drugs to extracellular vesicles (EVs) for deep tumor penetration.
  • To engineer a cell membrane-based vector for enhanced drug delivery and tumor targeting.
  • To investigate the potential of an EVs-hitchhiking strategy for improving phototherapy outcomes.

Main Methods:

  • An engineered cell membrane-based vector was designed, incorporating the AS1411 aptamer for tumor targeting and vesicular stomatitis virus glycoprotein (VSV-G) for membrane fusion.
  • A photosensitizer was utilized as the therapeutic agent, encapsulated within the vector for stability and optimal loading.
  • The vector facilitated the transfer of photosensitizers to tumor cell membranes, followed by hitchhiking onto EVs for deep tumor tissue penetration.

Main Results:

  • The novel EVs-hitchhiking strategy enabled efficient deep penetration of photosensitizers into solid tumors.
  • Layer-by-layer transfer of photosensitizers via EVs facilitated enhanced drug distribution within the tumor microenvironment.
  • The approach demonstrated improved efficacy in phototherapy due to deep tumor penetration.

Conclusions:

  • The engineered cell membrane-based vector provides an efficient means to attach drugs to EVs for enhanced tumor penetration.
  • The EVs-hitchhiking strategy holds significant potential for improving the delivery of therapeutic agents deep into tumor tissues.
  • This approach offers broad applicability for developing advanced drug delivery systems in cancer treatment.
Keywords:
Deep penetrationDrug deliveryEngineering cell membrane vesiclesMembrane fusion

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

660
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.0K

Related Concept Videos

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
469
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
975
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
365
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.0K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
313
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491